-
1
-
-
41549097751
-
Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: Implications from a clinical and patient perspective
-
Brooks DJ. Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective. Neuropsychiatr Dis Treat 2008;4:39-47. (Pubitemid 351460978)
-
(2008)
Neuropsychiatric Disease and Treatment
, vol.4
, Issue.1 A
, pp. 39-47
-
-
Brooks, D.J.1
-
2
-
-
35348935657
-
Optimizing pharmacotherapy:strategies to manage the wearing-off phenomenon
-
Tse W. Optimizing pharmacotherapy:strategies to manage the wearing-off phenomenon. J Am Med Dir Assoc 2006;7(Suppl 2):12-7.
-
(2006)
J Am Med Dir Assoc
, vol.7
, Issue.SUPPL. 2
, pp. 12-17
-
-
Tse, W.1
-
3
-
-
53049098765
-
A folyamatos dopaminerg stimuláció jelentocombining double acute accentsége a Parkinson-kór kezelésében
-
Takáts A. A folyamatos dopaminerg stimuláció jelentocombining double acute accentsége a Parkinson-kór kezelésében. LAM 2008;18:585-9.
-
(2008)
LAM
, vol.18
, pp. 585-589
-
-
Takáts, A.1
-
4
-
-
26444616750
-
Optimising levodopa therapy for management of Parkinson's disease
-
Stocchi F. Optimising levodopa therapy for management of Parkinson's disease. J Neurol 2005;252(Suppl 4):IV43-48.
-
(2005)
J Neurol
, vol.252
, Issue.SUPPL. 4
-
-
Stocchi, F.1
-
5
-
-
44949206362
-
Levodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: A retrospective, observational analysis of a large French cohort
-
DOI 10.1111/j.1468-1331.2008.02165.x
-
Damier P, Viallet F, Ziegler M, Bourdeix I, Rerat K. Levodopa/DDCI and entacapone is the preferred treatment for Parkinson's disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort. Eur J Neurol 2008;15:643-8. (Pubitemid 351814412)
-
(2008)
European Journal of Neurology
, vol.15
, Issue.7
, pp. 643-648
-
-
Damier, P.1
Viallet, F.2
Ziegler, M.3
Bourdeix, I.4
Rerat, K.5
-
6
-
-
34547191858
-
Medical management of levodopa-associated motor complications in patients with Parkinson's disease
-
DOI 10.2165/00023210-200721080-00005
-
Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs 2007;21:677-92. (Pubitemid 47121793)
-
(2007)
CNS Drugs
, vol.21
, Issue.8
, pp. 677-692
-
-
Jankovic, J.1
Stacy, M.2
-
7
-
-
43049164393
-
A Stalevo-kezelés magyarországi tapasztalatai és hatása a Parkinson-kórban szenvedõ betegek életminocombining double acute accentségére
-
Klivényi P, Vécsei L. A Stalevo-kezelés magyarországi tapasztalatai és hatása a Parkinson-kórban szenvedõ betegek életminocombining double acute accentségére. Ideggyógy Sz 2008;61:42-8.
-
(2008)
Ideggyógy Sz
, vol.61
, pp. 42-48
-
-
Klivényi, P.1
Vécsei, L.2
-
8
-
-
52649147137
-
Predictors of health-related quality of life in Parkinson's disease
-
Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G. Predictors of health-related quality of life in Parkinson's disease. Mov Disord 2008;23:1420-7.
-
(2008)
Mov Disord
, vol.23
, pp. 1420-1427
-
-
Forsaa, E.B.1
Larsen, J.P.2
Wentzel-Larsen, T.3
Herlofson, K.4
Alves, G.5
-
9
-
-
44949178691
-
Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease
-
DOI 10.2165/00023210-200822070-00003
-
Gallagher D, Schrag A. Impact of newer pharmacological treatments on quality of life in patients with Parkinson's Disease. CNS Drugs 2008:22(7):563-86. (Pubitemid 351822118)
-
(2008)
CNS Drugs
, vol.22
, Issue.7
, pp. 563-586
-
-
Gallagher, D.A.1
Schrag, A.2
-
10
-
-
3843063551
-
Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: Results of a large multicentre open-label study
-
Onofrij M, Thomas A, Vingerhoets F, Martin W, Giménez- Roldán S, Azulay JP, et al. Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multi-centre open-label study. J Neural Transm 2004:111:1053-63. (Pubitemid 39037126)
-
(2004)
Journal of Neural Transmission
, vol.111
, Issue.8
, pp. 1053-1063
-
-
Onofrj, M.1
Thomas, A.2
Vingerhoets, F.3
Martin, W.4
Gimenez-Roldan, S.5
Azulay, J.-P.6
Bernhard, G.7
Schmidt, W.8
Markabi, S.9
|